SCHEMBL26291600

SCHEMBL26291600

C=C(C)C(=O)OCOc1ccc2cc(-c3cccn3C)oc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ S1PR1 P21453 1/20 0.36
▸ S1PR3 Q99500 1/20 0.36
▸ ALDH1A1 P00352 6/20 0.35
▸ APP P05067 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ F2RL3 Q96RI0 3/20 0.35
▸ KDM4E B2RXH2 4/20 0.34
▸ MAPT P10636 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ POLB P06746 2/20 0.34
▸ TP53 P04637 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26291598 0.85 S1PR1 (0.36) RAB9ANPC1S1PR1S1PR3ALDH1A1
SCHEMBL26291463 0.82 RAB9A (0.51) RAB9ANPC1S1PR1S1PR3ALDH1A1
SCHEMBL23395701 0.82 ALDH1A1 (0.33) RAB9ANPC1ALDH1A1APPSMN1; SMN2
SCHEMBL26292135 0.81 RAB9A (0.38) RAB9ANPC1S1PR1S1PR3ALDH1A1
SCHEMBL23395535 0.79 MKNK1 (0.33) ALDH1A1F2RL3KDM4EHPGDMKNK1
SCHEMBL26291462 0.78 RAB9A (0.42) RAB9ANPC1S1PR1S1PR3ALDH1A1
SCHEMBL26291594 0.78 S1PR1 (0.41) S1PR1S1PR3ALDH1A1MAOBF2RL3
SCHEMBL26291630 0.77 APP (0.43) RAB9ANPC1S1PR1ALDH1A1APP
SCHEMBL26291681 0.76 KDM4E (0.52) RAB9ANPC1ALDH1A1SMN1; SMN2MAOB
SCHEMBL23395566 0.76 PTPN1 (0.48) RAB9ANPC1ALDH1A1APPSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D RAB9A 1119/4885NPC1 2727/4885S1PR1 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback